Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs MBody AI Ltd. (MBAI)
A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and MBody AI Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$0.92HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
MBAI
MBody AI Ltd.
$3.20HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
Total return — CVKD vs MBAI
growth of $100 · dividends reinvested · last 1yCVKD -93.0% (-93.0%/yr)MBAI -67.4% (-67.4%/yr)MBAI compounded faster over this window
CVKD MBAI
CVKD vs MBAI: by the numbers
- •CVKD is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | CVKD | MBAI |
|---|---|---|
| P/B ratio | 0.80 | 0.93 |
Profitability
| Metric | CVKD | MBAI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -282.13% | 120.45% |
| ROIC | -284.81% | -69.04% |
Go deeper
Dig into the metrics
Cadrenal Therapeutics, Inc. Common Stock ROEMBody AI ROECadrenal Therapeutics, Inc. Common Stock operating marginMBody AI operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthMBody AI revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowMBody AI free cash flow
Cadrenal Therapeutics, Inc. Common Stock & MBody AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.